Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Villain

Showing results (271-280 of 738) with videos related to

Pageof 74
Sort By:
Cellular Immunology|May 3, 2001
Prevention and reversal of experimental autoimmune myasthenia gravis by a monoclonal antibody against acetylcholine receptor-specific T cellsL Xu, M Villain, F S Galin, et al.
Archives Francaises De Pediatrie|January 1, 1991
[QT prolongation and circulatory arrest after an injection of erythromycin in a newborn infant]A Benoit, C Bodiou, E Villain, et al.
Orbit (Amsterdam, Netherlands)|April 20, 2018
Evisceration with autogenous scleral graft and bioceramic implantation within the modified scleral shell: 133 cases over 17 yearsJeremy Nadal, Vincent Daien, Jérôme Jacques, et al.
Archives of Internal Medicine|April 13, 2011
Visual impairment, optical correction, and their impact on activity limitations in elderly persons: the POLA studyVincent Daien, Karine Pérès, Max Villain, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 20, 2020
Advantages of everolimus therapeutic drug monitoring in oncology when drug-drug interaction is suspected: A case reportGeoffrey Strobbe, Diane Pannier, Ilyes Sakji, et al.
Cells|April 23, 2022
Mass Spectrometry for Neurobiomarker Discovery: The Relevance of Post-Translational ModificationsRita Azevedo, Chloé Jacquemin, Nicolas Villain, et al.
Acta Ophthalmologica|January 17, 2014
Visual acuity thresholds associated with activity limitations in the elderly. The Pathologies Oculaires Liées à l'Age studyVincent Daien, Karine Peres, Max Villain, et al.
Journal of Pharmaceutical Sciences|March 6, 2025
Transportation of protein drugs at hospital: Comparison of mechanical stress occurring during pneumatic transportation and hand-carried transportPauline Barreau, Fréderic Feutry, Marie Abelé, et al.
Bioresource Technology|February 27, 2026
Purification process coupling membrane filtration and adsorption for deep eutectic solvent (DES) recycling after lignin extractionP L Pasquet, Y Abdou, M Villain-Gambier, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|January 1, 1996
Differential effect of ischemia/reperfusion on pigmented and albino rabbit retinaA Muller, M Villain, B Favreau, et al.
Pageof 74

Showing results (271-280 of 738) with videos related to

Sort By:
Pageof 74
Cellular Immunology|May 3, 2001
Prevention and reversal of experimental autoimmune myasthenia gravis by a monoclonal antibody against acetylcholine receptor-specific T cellsL Xu, M Villain, F S Galin, et al.
Archives Francaises De Pediatrie|January 1, 1991
[QT prolongation and circulatory arrest after an injection of erythromycin in a newborn infant]A Benoit, C Bodiou, E Villain, et al.
Orbit (Amsterdam, Netherlands)|April 20, 2018
Evisceration with autogenous scleral graft and bioceramic implantation within the modified scleral shell: 133 cases over 17 yearsJeremy Nadal, Vincent Daien, Jérôme Jacques, et al.
Archives of Internal Medicine|April 13, 2011
Visual impairment, optical correction, and their impact on activity limitations in elderly persons: the POLA studyVincent Daien, Karine Pérès, Max Villain, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 20, 2020
Advantages of everolimus therapeutic drug monitoring in oncology when drug-drug interaction is suspected: A case reportGeoffrey Strobbe, Diane Pannier, Ilyes Sakji, et al.
Cells|April 23, 2022
Mass Spectrometry for Neurobiomarker Discovery: The Relevance of Post-Translational ModificationsRita Azevedo, Chloé Jacquemin, Nicolas Villain, et al.
Acta Ophthalmologica|January 17, 2014
Visual acuity thresholds associated with activity limitations in the elderly. The Pathologies Oculaires Liées à l'Age studyVincent Daien, Karine Peres, Max Villain, et al.
Journal of Pharmaceutical Sciences|March 6, 2025
Transportation of protein drugs at hospital: Comparison of mechanical stress occurring during pneumatic transportation and hand-carried transportPauline Barreau, Fréderic Feutry, Marie Abelé, et al.
Bioresource Technology|February 27, 2026
Purification process coupling membrane filtration and adsorption for deep eutectic solvent (DES) recycling after lignin extractionP L Pasquet, Y Abdou, M Villain-Gambier, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|January 1, 1996
Differential effect of ischemia/reperfusion on pigmented and albino rabbit retinaA Muller, M Villain, B Favreau, et al.
Pageof 74